<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>70</volume><submitter>Ghizlane EA</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Acute pancreatitis (AP) is considered one of the potentially rare complications of severe hypertriglyceridemia (HTG). Multiple treatment modalities have been suggested for patients with HTG-AP, such as permanent removal of TG by plasmapheresis, the use of insulin and heparin to enhance lipoprotein lipase activity and fibrate therapy, but the data remains limited.&lt;h4>Case management&lt;/h4>we reported a case of 33-year-old women admitted for HTG-induced PA (HTG-AP). The patient had hypertriglyceridemia for 7 years under fibrate therapy as a medical history. On admission to our intensive care unit, his triglyceride level was 1060 mg/dl and the lipase level was 298 IU/L. An abdominal CT scan revealed stage E AP. The patient was treated with a low dose insulin infusion (0.05 </pubmed_abstract><journal>Annals of medicine and surgery (2012)</journal><pagination>102914</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8519797</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Hypertriglyceridemia revealing acute pancreatitis: A case report.</pubmed_title><pmcid>PMC8519797</pmcid><pubmed_authors>Manal M</pubmed_authors><pubmed_authors>Ghizlane EA</pubmed_authors><pubmed_authors>Salma T</pubmed_authors><pubmed_authors>Houssam B</pubmed_authors><pubmed_authors>Ikram Z</pubmed_authors><pubmed_authors>Brahim H</pubmed_authors><pubmed_authors>Abderrahim EK</pubmed_authors><pubmed_authors>Sanae EM</pubmed_authors><pubmed_authors>Mohammed M</pubmed_authors><pubmed_authors>Fatem-Zahra A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Hypertriglyceridemia revealing acute pancreatitis: A case report.</name><description>&lt;h4>Introduction&lt;/h4>Acute pancreatitis (AP) is considered one of the potentially rare complications of severe hypertriglyceridemia (HTG). Multiple treatment modalities have been suggested for patients with HTG-AP, such as permanent removal of TG by plasmapheresis, the use of insulin and heparin to enhance lipoprotein lipase activity and fibrate therapy, but the data remains limited.&lt;h4>Case management&lt;/h4>we reported a case of 33-year-old women admitted for HTG-induced PA (HTG-AP). The patient had hypertriglyceridemia for 7 years under fibrate therapy as a medical history. On admission to our intensive care unit, his triglyceride level was 1060 mg/dl and the lipase level was 298 IU/L. An abdominal CT scan revealed stage E AP. The patient was treated with a low dose insulin infusion (0.05 </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2025-04-04T10:55:36.737Z</modification><creation>2025-04-04T10:55:36.737Z</creation></dates><accession>S-EPMC8519797</accession><cross_references><pubmed>34691438</pubmed><doi>10.1016/j.amsu.2021.102914</doi></cross_references></HashMap>